Document:

Filed by Automated Filing Services Inc. (604) 609-0244 - MERIDIAN CO., LTD. - Exhibit 4.3

 Exhibit 4.3 

EUROPEAN MARKETING CONSULTING AGREEMENT 

 This Marketing Agreement (“Agreement”) is dated
  for reference this 1st day of April 2005 

	 BETWEEN:  	 MS. HONG IN YOO of B-102 Human villa 38-199, Yongmoon-dong, Yongmoon-gu,
      Seoul,  Korea (“Consultant”)  
	  	 
	 AND:  	 MERIDIAN CO., LTD., of 4F, Heungseong Bldg., 197-3, Jamsilbon-dong, Songpa-gu
      Seoul,  Republic of Korea (“MERIDIAN”)  

BACKGROUND FACTS: 

	 	 A.      	 CONSULTANT has extensive experience in marketing and research in European
      territory. 
	 
	 	 B.      	 MERIDIAN considers it to be in its best interest to engage CONSULTANT
      to receive marketing consulting services for its products in Europe on the
      terms and subject to the conditions hereinafter set forth. 

 In consideration of the covenants and Agreements herein
  contained, and other good and valuable consideration, the receipt and sufficiency
  of which are hereby acknowledged by the Parties, the Parties hereby agree as
  follows: 

 A. SERVICES 

 CONSULTANT shall be responsible for investigating potential
  marketing venues and methods appropriate for Europe and shall research competitor
  products for the purpose of establishing a competitive pricing structure and
  marketing methods.

 CONSULTANT also shall be responsible for conducting market
  research in European territory and preparing a marketing plan for MERIDIAN.

 CONSULTANT during his research shall communicate with representatives
  from the Company from time to time during the market development process and
  shall assist the Company for as the agents of EU member countries and other
  European nations for the Company for all business the Company conducts within
  the European territory. 

B. CONSIDERATION 

	 2.1      	 In consideration for the Services, MERIDIAN shall
        pay CONSULTANT the minimum monthly retainer of $14,000 US or number
        of the MERIDIAN’s common shares equivalent to the value of $14,000
        US ($0.20 US per share) invoiced in advance each month. 

C. EXPENSES AND COSTS 

	 3.1      	 Company shall pay all costs and expenses incurred
        by CONSULTANT, its directors, officers, employees, and agents, in carrying
        out its duties and obligations pursuant to the provisions of this Agreement,
        excluding CONSULTANT's general and administrative expenses and costs,
        but including and not limited to the following costs and expenses: 

	 

	 a.      	
Travel expenses, including, but not limited to transportation, lodging and food expenses, when such travel is conducted on behalf of the Company. (If requested)	
	 
	
b.      		
Seminars, expositions, marketing campaign.	
	 
	
c.      		
Printing and publication costs of brochures and marketing materials.	
	 
	
d.      		
Postage on all packages mailed.	
	 

 

	 3.2      	 All expenses and costs shall be paid by cash or number of the MERIDIAN’s
      common shares equivalent to the total amount. 

D. TERM 

 CONSULTANT will prepare a business plan and present the first
  draft version to MARIDIAN within two months from the date first written above.

E. CONFIDENTIALITY 

	 5.1      	 All reports, documents, concepts and products together
        with any business contracts or any business opportunities prepared, produced,
        developed or acquired by CONSULTANT, directly or indirectly, in connection
        with CONSULTANT performing the Services (collectively, the “Work
        Product”) will belong exclusively to MERIDIAN which will be entitled
        to all rights, interest, profits or benefits in respect thereof. 

	 
	 5.2      	 No copies, summaries or other reproductions of any
        Work Product shall be made by CONSULTANT without the express permission
        of MERIDIAN, provided that CONSULTANT is given permission to maintain
        one copy of the Work Product for its own use. 

	 
	 5.3      	 CONSULTANT will not disclose any information, documents
        or Work Product which is developed by CONSULTANT or to which CONSULTANT
        may have access by virtue of its performance of the Services to any person
        not expressly authorized by MERIDIAN for that purpose. CONSULTANT will
        comply with such directions as MERIDIAN may make to ensure the safeguarding
        or confidentiality of all such information, documents and Work Product.
      

	 
	 5.4      	 CONSULTANT may not disseminate nor distribute to
        the media, members of the public, shareholders of MERIDIAN, prospective
        investors, members of the investment or brokerage community, securities
        regulators or any other third party any of the Work Product or any other
        written or printed information about MERIDIAN or its business, without
        MERIDIAN first reviewing and approving the Work Product or other information
        prior to dissemination or distribution. 

 F. LAW

	 6.1      	 This agreement shall be governed by and construed in accordance with
      the laws of the Republic of Korea and the parties hereby irrevocably attorn
      to the courts of such country. 

IN WITNESS THEREOF, the parties above have caused this Agreement to be duly executed, as of the day and year set out below. 

	_______________________________	____________
	 HONG INN YOO  	 Date  
	 	 
	 	 
	 MERIDIAN CO., LTD.,  	  
	 	 
	 By:  ____________________________ 	____________
	 Hyeon Seong Myeong, CEO/President  	 DateFiled by Automated Filing Services Inc. (604) 609-0244 - MERIDIAN CO., LTD. - Exhibit 4.4

 Exhibit 4.4 

 CLINICAL RESEARCH CONSULTING AGREEMENT (renewed) 

THIS CLITICAL RESEARCH AGREEMENT is made effective this 1st day of 2005 by and; 

BETWEEN: 

  
     WOO-KYUNG SEO, 403-909, 4th Block, Tanhyun Village, Tanhyun-Dong, Ilsan-Ku,
      Koyang-City, Kyeonggi-Do, Korea (hereinafter referred to as “CONSULTANT”)
      

  

AND: 

  
     MERIDIAN CO., LTD., of 9Fl., Seoil Bldg. 222, Jamsilbon-dong, Songpa-gu
      Seoul, Republic of Korea (hereinafter referred to as “MERIDIAN”)
      

  

 WHEREAS:

A. MERIDIAN is engaged in the research, development,
  manufacturing and sales of medical devices mainly for the Oriental and Natural/Alternative
  Medicine; 

B. CONSULTANT is a medical professional providing clinical
  research services in the North American regulatory standard; and 

C. MERIDIAN considers it to be in its best interest
  to engage CONSULTANT to receive clinical research consulting services for its
  products in North America on the terms and subject to the conditions hereinafter
  set forth. 

NOW THEREFORE THIS AGREEMENT WITNESS THAT the parties mutually agree as
  follows: 

A. ENGAGEMENT 

	 1.3      	 Subject to the terms and conditions hereof, MERIDIAN
        hereby engages CONSULTANT to receive the clinical research services set
        out in Section 2 hereof (the “Services”). 

	 
	 1.4      	 CONSULTANT’s obligation to perform the Services
        shall commence following the completion of the list of the Services, and
        will continue from the Effective Date until terminated in accordance with
        Article 4 hereof (the “Term”). 

B. SERVICES 

	 2.1      	 Conduct the medical research on every products of
        MERIDIAN, which is acceptable in the US medical industry. 

	 
	 2.2      	 Prepare the appropriate research results for the
        Meridian Products to meet the FDA standard. 

	 
	 2.3      	 Examine the products for FDA regulations (510(k)),
        Pre-market Approval, Investigation Device Exemption. 

C.  CONSIDERATION 

	 3.1      	 In consideration for the Services, MERIDIAN shall
        pay CONSULTANT 62,400,000 Korean Won (equivalent to $62,400 US) or
        number of the MERIDIAN’s common shares equivalent to the value of
        $62,400 US ($0.20 US per share). 

 D. EXPENSES AND COSTS 

	4.1	All expenses related the Services shall be included in the payment set
      out in Section 3. 

E. TERMINATION AND RENEWAL 

	 5.1      	 This agreement may be terminated by MERIDIAN upon
        the occurrence of any default by CONSULTANT by giving written notice to
        CONSULTANT by giving written notice to CONSULTANT specifying the nature
        of the default. A default will be defined as the occurrence of any one
        ore more of the following: 

	 

	 	 i.      	 CONSULTANT fails to perform any of the Services
        in the manner or within the time required herein or commits or permits
        a breach of or default in any of CONSULTANT’s covenants, duties
        or obligations hereunder; or 

	 
	 	 ii.      	 MERIDIAN acting reasonably determines that CONSULTANT
        or any of its principals, directors, officers, agents or employees has
        acted, is acting or is likely to act in a manner detrimental to MERIDIAN
        or has violated the confidentiality of any information as provided for
        in this agreement. 

F. CONFIDENTIALITY 

	 6.1      	 All reports, documents, concepts and products together
        with any business contracts or any business opportunities prepared, produced,
        developed or acquired by CONSULTANT, directly or indirectly, in connection
        with CONSULTANT performing the Services (collectively, the “Work
        Product”) will belong exclusively to MERIDIAN which will be entitled
        to all rights, interest, profits or benefits in respect thereof. 

	 
	 6.2      	 No copies, summaries or other reproductions of any
        Work Product shall be made by CONSULTANT without the express permission
        of MERIDIAN, provided that CONSULTANT is given permission to maintain
        one copy of the Work Product for its own use. 

	 
	 6.3      	 CONSULTANT will not disclose any information, documents
        or Work Product which is developed by CONSULTANT or to which CONSULTANT
        may have access by virtue of its performance of the Services to any person
        not expressly authorized by MERIDIAN for that purpose. CONSULTANT will
        comply with such directions as MERIDIAN may make to ensure the safeguarding
        or confidentiality of all such information, documents and Work Product.
      

 G. LAW

	 7.1      	 This agreement shall be governed by and construed in accordance with
      the laws of the Republic of Korea and the parties hereby irrevocably attorney
      to the courts of such country. 

IN WITNESS THEREOF, the parties above have caused this Agreement to be duly executed, as of the day and year set out below. 

	 WOO-KYUNG SEO  	  
	 	 
	_____________________________	______________
	  	 Date  
	 	 
	 MERIDIAN CO., LTD.,  	  
	 	 
	 By:  _____________________________	_____________ 
	 Hyeon Seong Myeong, CEO/President  	 Date

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00086-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00086-of-00352.parquet"}]]